sábado, 10 de abril de 2021

Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients - The Lancet Regional Health – Western Pacific

Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients - The Lancet Regional Health – Western Pacific

No hay comentarios:

Publicar un comentario